1Glorieux FH,Rauch F,Plotkin H,et al. Type V osteogenesis imperfecta: A new form of brittle bone disease [J]. J Bone Miner Res,2000,15:1650-1658. 被引量：1
2Glorieux FH,Ward LM,Rauch F,et al. Osteogenesis imperfecta type Ⅵ: a form of brittle bone disease with a mineralization defect [J]. J Bone Miner Res ,2002,17:30-38. 被引量：1
3Ward LM, Rauch F, Travers R, et al. Osteogenesis imperfecta type Ⅶ:an autosomal recessive form of brittle bone disease [J]. Bone,2002,31:12-18. 被引量：1
4Rauch F,Travers R,Parfitt AM,et al. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta [J]. Bone,2000,26:581-589. 被引量：1
5Boyde A,Travers R,Glorieux FH,et al. The mineralization density of iliac crest bone from children with osteogenesis imperfecta[J]. Calcif Tissue Int, 1999,64:185-190. 被引量：1
6Jones S J,Glorieux FH,Travers R,et al. The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: A survey using backscattered electron imaging [J]. Calcif Tissue Int,1999,64:8-17. 被引量：1
7Cranney A,Wells G,Willan A,et al. Meta-analysis of alendronate for the treatment of postmenopausal women [J]. Endocrine Rev, 2002,23:508-516. 被引量：1
8Kushida K, Shiraki M, Nakamura T, et al. The efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: a randomized, double-blind, active-controlled, double-dummy trial [J]. Curr Ther Res Clin Exp,2002 ,63 :606-620. 被引量：1
9Plotkin H, Rauch F, Bishop NJ, et al. Pamidronate treatment of seve re osteogenesis imperfecta in children under 3 years of age [J]. J Clin Endocrinol Metab,2000,85:1846-1850. 被引量：1
10Shaw N, Boivin C, Crabtree N. Intravenous pamidronate in juvenile osteoporosis[J]. Arch Dis Child ,2000,83:143-145. 被引量：1
3Naeem M,Sheikh S,Ahmad W.A mutation in CTSK gene in an autosomal recessive pycnodysostosis family of Pakistani origin.BMC Med Genet,2009,10:76. 被引量：1
4Mujawar Q,Naganoor R,Patil H,et al.Pycnodysostosis with unusual findings:a case report.Cases.J,2009,2:6544. 被引量：1
5Schilling AF,Mülhausen C,Lehmann W,et al.High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.Osteoporos Int,2007,18 (5):659-669. 被引量：1
6Fleming KW,Barest G,Sakai O.Dental and facial bone abnormalities in pyknodysostosis:CT findings.AJNR Am J Neuroradiol,2007,28 (1):132-134. 被引量：1
7Gelb BD,Moissoglu K,Zhang J,et al.Cathepsin K:isolation and characterization of the murine cDNA and genomic sequence,the homologue of the human pycnodysostosis gene.Biochem Mol Med,1996,59(2):200-206. 被引量：1
8Polymeropoulos MH,Ortiz De Luna RI,Ide SE,et al.The gene for pycnodysostosis maps to human chromosome 1cen-q21.Nat Genet,1995,10 (2):238-239. 被引量：1
9Gelb BD,Edelson JG,Desnick RJ.Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping.Nat Genet,1995,10(2):235-237. 被引量：1
